Skip to main content

Table 2 Groups of cynomolgus monkeys of the Macaca fascicularis strain for IV and IM administration of different doses of K1-70™

From: Preclinical studies on the toxicology, pharmacokinetics and safety of K1-70TM a human monoclonal autoantibody to the TSH receptor with TSH antagonist activity

Group

Dose route

Dose level (mg/kg/dose)

Number of animals

Subgroup 1

Toxicity

Treatment free

Male

Female

Male

Female

1

IV

0 (control)

3

3

2

2

2

IV

10 (low)

3

3

3

IV

30 (intermediate)

3

3

4

IV

100 (high)

3

3

2

2

5

IM

5 mg per dose (low)

3

3

2

2

  1. IV intravenous infusion; IM intramuscular injection